Home › Disturbo depressivo maggiore › Arkansas › Little Rock
Studi clinici su Disturbo depressivo maggiore a Little Rock, AR
14 studi su Disturbo depressivo maggiore cercano partecipanti presso sedi a Little Rock e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
In reclutamentoFase 3
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
In reclutamentoFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · a 15 mi di distanza
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
In reclutamentoFase 3
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · a 15 mi di distanza
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
In reclutamentoFase 3
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
In reclutamentoFase 4
- Neurocrine Clinical Site, Bryant · a 15 mi di distanza
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
In reclutamentoFase 3
- SanRo Clinical Research Group, Bryant · a 15 mi di distanza
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
In reclutamentoFase 2
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
In reclutamentoFase 2
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Bryant · a 15 mi di distanza
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
In reclutamentoFase 3
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · a 15 mi di distanza
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
In reclutamentoFase 2
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
In reclutamentoFase 2
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
In reclutamentoFase 3
- Neurocrine Clinical Site, Little Rock
Studi su Disturbo depressivo maggiore in altre città
- New York City, NY36 studi
- Boston, MA31 studi
- Atlanta, GA25 studi
- Philadelphia, PA23 studi
- Orlando, FL19 studi
- Miami, FL18 studi
- Chicago, IL17 studi
- Tampa, FL17 studi
- San Diego, CA16 studi
- Houston, TX16 studi
- Austin, TX13 studi
- Las Vegas, NV13 studi
Altri studi a Little Rock
- Schizofrenia19 studi
- Cancro (tutti i tipi)14 studi
- Leucemia mieloide acuta13 studi
- Cancro del polmone non a piccole cellule13 studi
- Obesità11 studi
- Cancro dell'endometrio10 studi
- Depressione10 studi
- Diabete di tipo 210 studi
- Cancro ai polmoni9 studi
- Malattie cardiovascolari9 studi
- Cancro della vescica9 studi
- Insufficienza cardiaca9 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.